Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROXYPROPYL CELLULOSE vs IBALIZUMAB-UIYK: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HYDROXYPROPYL CELLULOSE vs IBALIZUMAB-UIYK: Safety Overview

Metric HYDROXYPROPYL CELLULOSE IBALIZUMAB-UIYK
Total FAERS Reports 296 418
Deaths Reported 0 31
Death Rate N/A 7.4%
Hospitalizations 3 94
Average Patient Age 64.1 yrs 56.0 yrs
% Female Patients 91.2% 22.8%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Bausch & Lomb Incorporated N/A
Route OPHTHALMIC N/A
Marketing Status Discontinued Prescription